TMEM219 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.80049999856757E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.816780E-04 |
Normal-vs-Stage2 |
1.363610E-02 |
Normal-vs-Stage3 |
1.96770999999485E-05 |
Normal-vs-Stage4 |
2.30889999996986E-06 |
Stage1-vs-Stage2 |
9.110800E-01 |
Stage1-vs-Stage3 |
5.801400E-01 |
Stage1-vs-Stage4 |
2.363600E-01 |
Stage2-vs-Stage3 |
7.827200E-01 |
Stage2-vs-Stage4 |
4.660000E-01 |
Stage3-vs-Stage4 |
5.135800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.39060000017943E-07 |
Normal-vs-AfricanAmerican |
1.85876999999612E-05 |
Normal-vs-Asian |
7.045400E-01 |
Caucasian-vs-AfricanAmerican |
9.382000E-02 |
Caucasian-vs-Asian |
1.199370E-01 |
AfricanAmerican-vs-Asian |
1.036600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.92269999998995E-06 |
Normal-vs-Female |
3.33479999947706E-07 |
Male-vs-Female |
9.585000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.979900E-02 |
Normal-vs-Age(41-60Yrs) |
4.72630000003527E-06 |
Normal-vs-Age(61-80Yrs) |
4.46179999999963E-05 |
Normal-vs-Age(81-100Yrs) |
7.52030000000792E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.413200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.455000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.095300E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.094200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.761850E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.699700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.253800E-02 |
Normal-vs-Grade 2 |
6.398600E-04 |
Normal-vs-Grade 3 |
1.97720000039148E-07 |
Normal-vs-Grade 4 |
4.11879999999698E-05 |
Grade 1-vs-Grade 2 |
4.255800E-01 |
Grade 1-vs-Grade 3 |
1.992780E-01 |
Grade 1-vs-Grade 4 |
4.081900E-02 |
Grade 2-vs-Grade 3 |
7.242600E-01 |
Grade 2-vs-Grade 4 |
1.569390E-01 |
Grade 3-vs-Grade 4 |
1.856780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.63343999999288E-05 |
Normal-vs-ccB subtype |
5.821900E-03 |
ccA subtype-vs-ccB subtype |
2.275000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.54409999999894E-05 |
Normal-vs-N1 |
1.376260E-02 |
N0-vs-N1 |
4.041800E-01 |
|
|